Epitope

By Targets:	Aldehyde Dehydrogenase (ALDH) (1) Amyloid-β (3) Antibiotic (12) Apoptosis (4) Arenavirus (5) Autophagy (4) Bacterial (13) Biochemical Assay Reagents (6) c-Met/HGFR (1) CD20 (1) CMV (1) DNA/RNA Synthesis (2) Drug Metabolite (4) EBV (5) EGFR (3) Endogenous Metabolite (11) Ferroptosis (1) GABA Receptor (1) GnRH Receptor (11) HBV (1) HCV (1) Histamine Receptor (2) HIV (8) HPV (2) HSV (1) Influenza Virus (10) Interleukin Related (1) Ligands for E3 Ligase (1) Mitophagy (1) Mucin (3) Na+/K+ ATPase (1) Opioid Receptor (1) Orthopoxvirus (1) Parasite (2) RABV (3) Reactive Oxygen Species (1) RSV (3) SARS-CoV (3) Tau Protein (2) Thyroid Hormone Receptor (1) Tyrosinase (1)
By Research Areas:	Cancer (32) Cardiovascular Disease (2) Infection (29) Inflammation/Immunology (150) Metabolic Disease (6) Neurological Disease (7)

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P4020

2F5 epitope	HIV	Others
2F5 epitope, a peptide gp41 (659-671), comprises the entire epitope for one of the three known antibodies capable of neutralizing a broad spectrum of primary HIV-1 isolates and is the only such epitope that is sequential. 2F5 epitope is recognized by broadly neutralizing antibodies 2F5 .

HY-P1881

HPV16-E711-20 epitope	HPV	Cancer
HPV16-E711-20 epitope is a well-known HLA-A ^0201-restricted human cytotoxic T lymphocyte (CTL) epitope* of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. HPV16 CTL epitopes may be good candidates for the development of an effective peptide-based antitumor vaccine .

HY-P5503

Pol (476-484), HIV-1 RT Epitope	HIV	Others
Pol (476-484), HIV-1 RT Epitope is a biological active peptide. (This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A0201-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope* processed and presented in HIV-1-infected cell lines.)

HY-P5305A

*GAD65(247-266) epitope* TFA**	GABA Receptor	Metabolic Disease
GAD65(247-266) epitope TFA is the T cell epitopes of islet antigens，binding to I-A ^g7 (type I diabetes-associated molecule) competitively with poor affinity. GAD65 refers to Glutamic Acid Decarboxylase 65，involved in the conversion of glutamate to gamma-aminobutyric acid (GABA) .

HY-P99856

Docaravimab	RABV	Infection
Docaravimab is an antibody, targeting *ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope* G-III**. Docaravimab can be used in research of Rabies .

HY-P990073

Davutamig REGN-5093	c-Met/HGFR	Cancer
Davutamig (REGN-5093) is a human immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic .

HY-P4045

HBV Seq2 aa:208-216

HBV Infection

HBV Seq2 aa:208-216, a HBsAg derived CD8 epitope peptide, is studied as part of Large envelope protein from Hepatitis B virus .

HBV Seq2 aa:208-216	HBV	Infection
HBV Seq2 aa:208-216, a HBsAg derived CD8 epitope peptide, is studied as part of Large envelope protein from Hepatitis B virus .

HY-P3813

Tyrosinase (206-214), human	Tyrosinase	Inflammation/Immunology Cancer
Tyrosinase (206-214), human (AFLPWHRLF), a 9-amino acid peptide, is a tyrosinase epitope. Tyrosinase (206-214), human can be recognized by HLA-A24 restricted, tumor-infiltrating lymphocytes (TIL) .

HY-P99471

Bepranemab UCB 0107	Tau Protein	Neurological Disease
Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research .

HY-P4032

HCV Peptide (35-44)	HCV	Inflammation/Immunology
HCV Peptide (35-44), a HCV core protein at positions 35 to 44, is a HLA-A2-restricted CTL epitope. HCV Peptide (35-44) inhibits NK cell activity via two distinct mechanisms, directly via KIR2DL2/3, and synergistically via the CD94:NKG2A receptor .

HY-P99551

Tosatoxumab KBSA301; AR-301	Antibiotic	Infection
Tosatoxumab (AR-301; KBSA301) is a human immunoglobulin G1 monoclonal antibody that specifically neutralizes alpha-toxin (alpha-hemolysin; Hla) of S. aureus. Tosatoxumab binds to an N-terminal epitope of alpha-toxin, thereby preventing functional toxin pore oligomerisation. Tosatoxumab has the potential for passive immunotherapy in the S. aureus pneumonia as an adjunctive therapy to standard antibiotic agent .

HY-P1762

Influenza NP (147-155)

Influenza Virus Infection

Influenza NP (147-155) is a K ^d restricted epitope from influenza nucleoprotein .

Influenza NP (147-155)	Influenza Virus	Infection
Influenza NP (147-155) is a K ^d restricted epitope from influenza nucleoprotein .

HY-P1862

HSV-gB2 (498-505)	HSV	Infection
HSV-gB2 (498-505) is an immunodominant epitope from herpes simplex virus (HSV) glycoprotein B residues 498-505, acts as H-2Kb-restricted and HSV-1/2-cross-reactive cytotoxic T-lymphocyte (CTL) recognition epitope .

HY-P1762A

Influenza NP (147-155) (TFA)

Influenza Virus Infection

Influenza NP (147-155) TFA is a K ^d restricted epitope from influenza nucleoprotein .
HY-P1780

CEF20

CMV Infection

CEF20 is an HLA-A*0201-restricted epitope from cytomegalovirus pp65 (495-503).
HY-P99628

Futuximab

EGFR Cancer

Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity .
HY-P99968

Clivatuzumab

Mucin Cancer

Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers .

Influenza NP (147-155) (TFA)	Influenza Virus	Infection
Influenza NP (147-155) TFA is a K ^d restricted epitope from influenza nucleoprotein .

CEF20	CMV	Infection
CEF20 is an HLA-A0201-restricted epitope* from cytomegalovirus pp65 (495-503).

Futuximab	EGFR	Cancer
Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity .

Clivatuzumab	Mucin	Cancer
Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers .

HY-P0137

CEF1, Influenza Matrix Protein M1 (58-66)	Influenza Virus	Infection
CEF1, Influenza Matrix Protein M1 (58-66) is an epitope derived from the matrix protein of the influenza A virus .

HY-P99615

Felvizumab

SB 209763; RSHZ19
RSV Infection

Felvizumab (SB 209763) is a humanized IgG1κ monoclonal antibody directed to distinct neutralizing epitopes on the F glycoprotein of RSV .

Felvizumab SB 209763; RSHZ19	RSV	Infection
Felvizumab (SB 209763) is a humanized IgG1κ monoclonal antibody directed to distinct neutralizing epitopes on the F glycoprotein of RSV .

HY-P1854

β-Amyloid (1-9)	Amyloid-β	Neurological Disease
β-Amyloid (1-9), an N-terminal fragment of beta amyloid, consists of amino acid residues 1 to 9. β-Amyloid (1-9) contains a B cell epitope, but it does not include T cell epitopes. Omission of residues 1 to 9 from the full-length Alzheimer'sβ-Amyloid peptide 1 to 40 does not prevent the peptide from forming amyloid fibrils or eliminate fibril polymorphism .

HY-P1757

HIV p17 Gag (77-85)

HIV Infection

HIV p17 Gag (77-85) is an HLA-A*0201(A2)-restricted CTL epitope, used in the research of anti-HIV .
HY-P1837

Influenza HA (518-526)

Influenza Virus Infection

Influenza HA (518-526) is an H-2K ^d-restricted epitope of the influenza virus hemagglutinin comprised amino acids 533 to 541 .
HY-P10296

p60 (217–225)

Endogenous Metabolite Infection

p60 (217–225) is the subdominant epitope of Listeria monocytogenes, which combines with H-2K ^d MHC class I molecules .

HIV p17 Gag (77-85)	HIV	Infection
HIV p17 Gag (77-85) is an HLA-A0201(A2)-restricted CTL epitope*, used in the research of anti-HIV .

Influenza HA (518-526)	Influenza Virus	Infection
Influenza HA (518-526) is an H-2K ^d-restricted epitope of the influenza virus hemagglutinin comprised amino acids 533 to 541 .

p60 (217–225)	Endogenous Metabolite	Infection
p60 (217–225) is the subdominant epitope of Listeria monocytogenes, which combines with H-2K ^d MHC class I molecules .

HY-B1610K

Sodium Citrate Buffer, 0.5M, pH 5.5	Biochemical Assay Reagents	Others
Sodium citrate buffer, 0.5M, pH 5.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer 0.5M pH 5.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer 0.5M pH 5.5 is the preferred solution for most antibodies. .

HY-B1610M

Sodium Citrate Buffer, 0.5M, pH 6.5	Biochemical Assay Reagents	Others
Sodium citrate buffer, 0.5M, pH 6.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 6.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 6.5 is the preferred solution for most antibodies .

HY-P1890

CEF14, EBV Rta Protein (28-37)

EBV Infection

CEF14, EBV Rta Protein (28-37) is the HLA A24-restricted epitope from Epstein-Barr Virus Rta protein (28-37).

CEF14, EBV Rta Protein (28-37)	EBV	Infection
CEF14, EBV Rta Protein (28-37) is the HLA A24-restricted epitope from Epstein-Barr Virus Rta protein (28-37).

HY-P99380

Zanidatamab ZW 25	EGFR	Cancer
Zanidatamab (ZW25) is a humanised, bispecific monoclonal antibody targeting 2 distinct HER2 epitopes (ECD2 and ECD4). Zanidatamab has anti-tumour activity .

HY-P99586

Suptavumab REGN2222	RSV	Infection
Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection .

HY-P10251

HIV gp120 (318-327)	HIV	Infection
HIV gp120 (318-327) is a short sequence of the HIV-1 strain IIIB envelope peptide (rgpgrafvti) that corresponds to the conserved C-terminal region of the glycoprotein. HIV gp120 (318-327) is part of the HIV vaccine V3 peptide epitope, also known as the I10 peptide. However, HIV gp120 (318-327) lacks the A2 anchor residues recognized by epitope-specific CTLs but has structural features that confer promiscuous A2 binding .

HY-P1787

β-Amyloid (4-10)	Amyloid-β	Neurological Disease
β-Amyloid (4-10) is an epitope for the polyclonal anti-Aβ(1-42) antibody, reduces amyloid deposition in a transgenic Alzheimer disease mouse model .

HY-P5482

Epstein-barr virus BRLF1 (134-142)	EBV	Others
Epstein-barr virus BRLF1 (134-142) is a biological active peptide. (HLA-A11 restricted epitope from Epstein-Barr Virus BRLF1 (134-142).)

HY-P10433

EGFRvIII peptide	Apoptosis	Cancer
EGFRvIII peptide is an EGFRvIII-derived epitope for binding to MHC I molecules. EGFRvIII peptide induces apoptosis, and causes specific immune responses against glioblastoma, especially in combination with Flagellin B .

HY-P99859

Donanemab LY3002813	Amyloid-β	Neurological Disease
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research .

HY-P5475

BMLF1 (280–288)

EBV Others

BMLF1 (280–288) is a biological active peptide. (HLA A2.1-restricted epitope from Epstein-Barr Virus lytic protein BMLF1 (280-288).)
HY-P5470

LMP2A (426-434)

EBV Others

LMP2A (426-434) is a biological active peptide. (HLA A2.1-restricted epitope from Epstein-Barr Virus latent membrane protein LMP2 (426-434).)
HY-P1788

Influenza A NP(366-374) Strain A/PR/8/35

Influenza Virus Infection

Influenza A NP(366-374) Strain A/PR/8/35 is an H2-Db-restricted epitope from Influenza A/PR/8/35 nucleoprotein .

BMLF1 (280–288)	EBV	Others
BMLF1 (280–288) is a biological active peptide. (HLA A2.1-restricted epitope from Epstein-Barr Virus lytic protein BMLF1 (280-288).)

LMP2A (426-434)	EBV	Others
LMP2A (426-434) is a biological active peptide. (HLA A2.1-restricted epitope from Epstein-Barr Virus latent membrane protein LMP2 (426-434).)

Influenza A NP(366-374) Strain A/PR/8/35	Influenza Virus	Infection
Influenza A NP(366-374) Strain A/PR/8/35 is an H2-Db-restricted epitope from Influenza A/PR/8/35 nucleoprotein .

HY-P5930

HOXB7 8–25 MDM2 32-46	Ligands for E3 Ligase	Cancer
HOXB7 8–25 (MDM2 32-46) is an MDM2-derived peptide epitope and can elicit antigen-specifc and tumor-reactive CD4 ⁺ T cell responses .

HY-B1610N

Sodium Citrate Buffer, 0.1M, pH 4.0 1 Publications Verification	Biochemical Assay Reagents	Others
Sodium citrate buffer, 0.1M, pH 4.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.1M, pH 4.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.1M, pH 4.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.1M, pH 4.0 is used in the hydration of liposome film .

HY-P1857

CEF7, Influenza Virus NP (380-388)	Influenza Virus	Infection
CEF7, Influenza Virus NP (380-388) is a HLA-B ^08 restricted influenza virus nucleoprotein epitope*. Influenza virus NP functions as a key adapter molecule between virus and host cell processes .

HY-P2455

LLO (91-99) Listeriolysin O (91-99)	Bacterial	Inflammation/Immunology
LLO (91-99) (Listeriolysin O (91-99)), an exotoxin, is a class I MHC-restricted T-cell epitopes of listeriolysin (LLO). LLO (91-99) is an essential antigen for induction of T-cell mediated immunity in vivo .

HY-P99538

Ublituximab LFB-R603; TG-1101; TGTX-1101	CD20	Cancer
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects .

HY-P99634

Gatipotuzumab PankoMab	Mucin	Cancer
Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC) .

HY-B1610J

Sodium Citrate Buffer, 0.5M, pH 5.0	Biochemical Assay Reagents	Others
Sodium citrate buffer, 0.5M, pH 5.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 5.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 5.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.5M, pH 5.0 is used as solution for captisol in animal tumor models .

HY-P1571

Nucleoprotein (396-404) NP 396	Arenavirus	Inflammation/Immunology
Nucleoprotein (396-404) is the 396 to 404 fragment of lymphocytic choriomeningitis virus (LCMV). Nucleoprotein (396-404) is the H-2D(b)-restricted immunodominant epitope and can be used as a molecular model of viral antigen .

HY-P1885

HIV gag peptide (197-205)	HIV	Infection
HIV gag peptide (197-205) is a H-2K ^d-restricted epitope derived from the p24 portion of the HIV-1 gag protein, consists of amino acids 197-205 (AMQMLKETI) .

HY-P99435

Amubarvimab BRII-196	SARS-CoV	Infection
Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a K_D of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants .

HY-160060

MA3 aptamer sodium	Mucin	Cancer
MA3 aptamer sodium is an 86-base long DNA aptamer targeting the mucin MUC1. MA3 aptamer sodium binds to the peptide epitope of mucin 1 (MUC1) with a Kd of 38.3 nM and has minimal cross-reactivity with albumin .

HY-P1571A

Nucleoprotein (396-404) (TFA) NP 396 TFA	Arenavirus	Inflammation/Immunology
Nucleoprotein (396-404) TFA is the 396 to 404 fragment of lymphocytic choriomeningitis virus (LCMV). Nucleoprotein (396-404) TFA is the H-2D(b)-restricted immunodominant epitope and can be used as a molecular model of viral antigen .

HY-E70061

alpha-1,3-N-Acetylgalactosaminyltransferase (BgtA)	Others	Others
alpha-1,3-N-Acetylgalactosaminyltransferase (BgtA) is an acetylgalactose aminotransferase, which can be isolated from Helicobacter mustelae, and can specifically recognize Fucα1,2-Gal epitopes .

HY-P99727

Mazorelvimab SYN023	RABV	Infection
Mazorelvimab (SYN023) is a combination of CTB011 and CTB012 humanized monoclonal antibodies cocktail against rabies virus (RABV). Mezagitamab binds to non-overlapping epitopes on RABV glycoprotein (G). Mezagitamab has potential application in the prevention of rabies .

Cat. No.	Product Name

HY-L0119V

Asinex PPI Pre-Plated Library

3,253 compounds

Protein protein interactions (PPI) have pivotal roles in life processes. The studies showed that aberrant PPI are associated with various diseases. However, the design of modulators targeting PPI still faces tremendous challenges, such the difficult PPI interfaces for the drug design, lack of ligands reference, lack of guidance rules for the PPI modulators development and high-resolution PPI proteins structures.

The PPI Library comprises molecules of various sizes, frameworks, and shapes ranging from fragment-like entities to macrocyclic derivatives designed as secondary structure mimetics or as epitope mimetics. The designs cover β-turn / loop mimetics and α-helix mimetics. Since helices present at the interface in 62% of all protein-protein interactions. This library focused on designs including mimics with the substitution geometry of an a-helices, as well as designs that mimic the location of “hot-spot” side chains in helix-mediated PPIs.

Cat. No.	Product Name	Type

HY-B1610N

Sodium Citrate Buffer, 0.1M, pH 4.0

1 Publications Verification

Biochemical Assay Reagents

Sodium citrate buffer, 0.1M, pH 4.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.1M, pH 4.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.1M, pH 4.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.1M, pH 4.0 is used in the hydration of liposome film .

HY-B1610J

Sodium Citrate Buffer, 0.5M, pH 5.0

Biochemical Assay Reagents

Sodium citrate buffer, 0.5M, pH 5.0, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 5.0 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 5.0 is the preferred solution for most antibodies . Sodium citrate buffer, 0.5M, pH 5.0 is used as solution for captisol in animal tumor models .

HY-B1610K

Sodium Citrate Buffer, 0.5M, pH 5.5

Biochemical Assay Reagents

Sodium citrate buffer, 0.5M, pH 5.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer 0.5M pH 5.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer 0.5M pH 5.5 is the preferred solution for most antibodies. .

HY-B1610M

Sodium Citrate Buffer, 0.5M, pH 6.5

Biochemical Assay Reagents

Sodium citrate buffer, 0.5M, pH 6.5, is a commonly used buffer with main components are citric acid and sodium hydrogen phosphate. Sodium citrate buffer, 0.5M, pH 6.5 is used in heat induced epitope retrieval (HIER) methods to reverse the loss of antigenicity that occurs with some epitopes in formalin-fixed paraffin embedded tissues. Sodium citrate buffer, 0.5M, pH 6.5 is the preferred solution for most antibodies .

HY-E70053

alpha-1,3-Galactosyltransferase (GTB) alpha 1,3GT	Biochemical Assay Reagents
alpha-1,3-Galactosyltransferase (GTB) (alpha 1,3GT) catalyzes the synthesis of the xenoantigen or α-galactose (α-Gal) epitope. alpha-1,3-Galactosyltransferase (GTB) transfers galactose from UDP-Gal to type 1 or type 2, αFuc1→2βGal-R (H)-terminating acceptors .

HY-158459

A2G2F2 glycan A2G2F2(a1-3) glycan	Carbohydrates
A2G2F2 glycan (A2G2F2(a1-3) glycan) is a Lewis X polysaccharide containing two Lewis X epitopes and is a symmetric N-glycan. SLeX is a ligand for the cell adhesion molecule E-selectin, which is specifically expressed at sites of inflammatory lesions. Designing SLeX-polysaccharide conjugates to deliver drugs to inflammatory lesions .

HY-158273

2,4-D/BSA

Biochemical Assay Reagents

2,4-D/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158274

Gibberellins/BSA

Biochemical Assay Reagents

Gibberellins/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158277

Streptomycin/BSA

Biochemical Assay Reagents

Streptomycin/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158278

Aflatoxin B1/BSA

Biochemical Assay Reagents

Aflatoxin B1/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158279

Gentamicin/OVA

Biochemical Assay Reagents

Gentamicin/OVA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158280

Streptomycin/KLH

Biochemical Assay Reagents

Streptomycin/KLH is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158282

Pyrazinamide-KLH

Biochemical Assay Reagents

Pyrazinamide-KLH is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158286

Streptomycin/OVA

Biochemical Assay Reagents

Streptomycin/OVA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158299

Periplogenin/BSA

Biochemical Assay Reagents

Periplogenin/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158290

Natrexone/BSA

Biochemical Assay Reagents

Natrexone/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158291

Periplogenin/KLH

Biochemical Assay Reagents

Periplogenin/KLH is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158292

Digoxin-OVA

Biochemical Assay Reagents

Digoxin-OVA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158293

Toosendanin/OVA

Biochemical Assay Reagents

Toosendanin/OVA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158294

Toosendanin/BSA

Biochemical Assay Reagents

Toosendanin/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158295

IAA/BSA

Biochemical Assay Reagents

IAA/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158296

Tetracycline/OVA

Biochemical Assay Reagents

Tetracycline/OVA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158297

Histamine/OVA

Biochemical Assay Reagents

Histamine/OVA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158300

HCY/BSA

Biochemical Assay Reagents

HCY/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-161486

AOZ/OVA

Biochemical Assay Reagents

AOZ/OVA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-161478

Phosphoserine/BSA

Biochemical Assay Reagents

Phosphoserine/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .

HY-161493

1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid/BSA	Biochemical Assay Reagents
1-(2-Aminoethyl)-1H-pyrazol-4-ylphosphonic acid/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .

HY-161488

Eugenol/BSA

Biochemical Assay Reagents

Eugenol/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-161485

Gentamicin/BSA

Biochemical Assay Reagents

Gentamicin/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-161484

Penicillin G/OVA

Biochemical Assay Reagents

Penicillin G/OVA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-161487

AOZ/BSA

Biochemical Assay Reagents

AOZ/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158283

Ethambutol-BSA

Biochemical Assay Reagents

Ethambutol-BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-161482

Alginic acid/BSA

Biochemical Assay Reagents

Alginic acid/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-161480

Melamine/BSA

Biochemical Assay Reagents

Melamine/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .

HY-158285

25-OH Vitamin D3/BSA	Biochemical Assay Reagents
25-OH Vitamin D3/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .

HY-158287

2,4-D/KLH

Biochemical Assay Reagents

2,4-D/KLH is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158289

Isoniazid-KLH

Biochemical Assay Reagents

Isoniazid-KLH is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-161477

Histamine/BSA

Biochemical Assay Reagents

Histamine/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158275

Rifampin/BSA

Biochemical Assay Reagents

Rifampin/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158281

Aflatoxin B1/KLH

Biochemical Assay Reagents

Aflatoxin B1/KLH is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158298

Penicillin/BSA

Biochemical Assay Reagents

Penicillin/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158276

Rifampin/KLH

Biochemical Assay Reagents

Rifampin/KLH is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158267

Enrofloxacin/OVA

Biochemical Assay Reagents

Enrofloxacin/OVA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .

HY-158268

4-Hydroxynonenal/BSA	Biochemical Assay Reagents
4-Hydroxynonenal/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .

HY-158269

T4-BSA

Biochemical Assay Reagents

T4-BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158270

Ethambutol-KLH

Biochemical Assay Reagents

Ethambutol-KLH is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158284

Penicillin G/BSA

Biochemical Assay Reagents

Penicillin G/BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-158288

Pyrazinamide-BSA

Biochemical Assay Reagents

Pyrazinamide-BSA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-161479

Melamine/OVA

Biochemical Assay Reagents

Melamine/OVA is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
HY-161481

Melamine/bov igG

Biochemical Assay Reagents

Melamine/bov igG is a biochemical reagent that can be used as a biological material or organic compound for life science related research .

Cat. No.	Product Name	Target	Research Area

HY-P2514

*TET 830 modified/T-helper epitope* from tetanus toxoid**	Peptides	Inflammation/Immunology
TET 830 modified/T-helper epitope from tetanus toxoid is a modified T-helper epitope from tetanus toxoid. TET 830 modified/T-helper epitope from tetanus toxoid induces T-cells responses and is used as a helper peptide in vaccinations .

HY-P1509

*Rhodopsin Epitope* Tag**	Peptides	Neurological Disease
Rhodopsin Epitope Tag is a 9-amino acid peptide localized within the C-terminal region of bovine rhodopsin . Rhodopsin Epitope Tag is widely used as an epitope tag and can be recognized by a number of anti-rhodopsin antibodies.

HY-P5271

Influenza hemagglutinin (HA) epitope	Peptides	Others
Influenza hemagglutinin (HA) epitope is a polypeptide. Influenza hemagglutinin (HA) epitope is conjugated to keyhole limpet hemocyanin to generate anti-HA polyclonal antibodies following immunization of rabbits .

HY-P4020

2F5 epitope	HIV	Others
2F5 epitope, a peptide gp41 (659-671), comprises the entire epitope for one of the three known antibodies capable of neutralizing a broad spectrum of primary HIV-1 isolates and is the only such epitope that is sequential. 2F5 epitope is recognized by broadly neutralizing antibodies 2F5 .

HY-P5479

EE epitope	Peptides	Others
EE epitope is a biological active peptide. (This peptide is a 314 to 319 amino acids fragment of the middle T antigen of mouse polymavirus. Glu-Glu epitope peptide is widely used as an epitope tag.Pyroglutamyl (pGlu) peptides may spontaneously form when either Glutamine (Q) or Glutamic acid (E) is located at the sequence N-terminus. The conversion of Q or E to pGlu is a natural occurrence and in general it is believed that the hydrophobic γ-lactam ring of pGlu may play a role in peptide stability against gastrointestinal proteases. Pyroglutamyl peptides are therefore considered a normal subset of such peptides and are included as part of the peptide purity during HPLC analysis.)

HY-P5496

AAV2 Epitope	Peptides	Others
AAV2 Epitope is a biological active peptide. (This peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells.)

HY-P0325

*V5 Epitope* Tag Peptide TFA**	Peptides	Others
V5 Epitope Tag Peptide (TFA) is a tag peptide derived from a small epitope present on the P and V proteins of the paramyxovirus of simian virus 5.

HY-P1881

HPV16-E711-20 epitope	HPV	Cancer
HPV16-E711-20 epitope is a well-known HLA-A ^0201-restricted human cytotoxic T lymphocyte (CTL) epitope* of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. HPV16 CTL epitopes may be good candidates for the development of an effective peptide-based antitumor vaccine .

HY-P5503

Pol (476-484), HIV-1 RT Epitope	HIV	Others
Pol (476-484), HIV-1 RT Epitope is a biological active peptide. (This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A0201-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope* processed and presented in HIV-1-infected cell lines.)

HY-P5457

*BMP-2 Epitope* (73-92)**	Peptides	Others
BMP-2 Epitope (73-92) is a biological active peptide. (This is amino acids 73 to 92 fragment of bone morphogenetic protein (BMP) knuckle epitope. It is a member of transforming growth factor beta (TGF-b). This peptide fragment is able to raise alkaline phosphate activity in murine multipotent mesenchymal cells.)

HY-P5505

LCMV-derived p13 epitope	Peptides	Others
LCMV-derived p13 epitope is a biological active peptide. (An H-2Db restricted epitope, this peptide is amino acids 61 to 80 fragment of the lymphocytic choriomeningitis virus (LCMV) pre-glycoprotein polyprotein GP complex. LCMV has been routinely used for the study of adaptive immune responses to viral infection.)

HY-P5305A

*GAD65(247-266) epitope* TFA**	GABA Receptor	Metabolic Disease
GAD65(247-266) epitope TFA is the T cell epitopes of islet antigens，binding to I-A ^g7 (type I diabetes-associated molecule) competitively with poor affinity. GAD65 refers to Glutamic Acid Decarboxylase 65，involved in the conversion of glutamate to gamma-aminobutyric acid (GABA) .

HY-P5472

Tumour-associated MUC1 epitope	Peptides	Others
Tumour-associated MUC1 epitope is a biological active peptide. (This sequence is the hallmark of MUC1 mucin. MUC1 is a highly glycosylated type I transmembrane glycoprotein with a unique extracellular domain consisting of a variable number of tandem repeats (VNTR) of this 20 amino acid peptide. It is overexpressed on the cell surface of many human adenocarcinomas and hematological malignancies, including multiple myeloma and B-cell lymphoma, making MUC1 broadly applicable target for immunotherapeutic strategies.)

HY-P3073

Myelin Basic Protein (1-11)	Peptides	Inflammation/Immunology
Myelin Basic Protein (1-11) is an encephalitogenic epitope of myelin basic protein (MBP). Myelin Basic Protein (1-11) can be used for induction of experimental autoimmune encephalomyelitis (EAE) .

HY-P1917

Uty HY Peptide (246-254)	Peptides	Inflammation/Immunology
Uty HY Peptide (246-254), derived from the ubiquitously transcribed tetratricopeptide repeat gene on the Y chromosome (UTY) protein as an H-Y epitope, H-YD ^b, is a male-specific transplantation antigen H-Y .

HY-P4045

HBV Seq2 aa:208-216

HBV Infection

HBV Seq2 aa:208-216, a HBsAg derived CD8 epitope peptide, is studied as part of Large envelope protein from Hepatitis B virus .

HY-P1917A

Uty HY Peptide (246-254) (TFA)	Peptides	Inflammation/Immunology
Uty HY Peptide (246-254) TFA, derived from the ubiquitously transcribed tetratricopeptide repeat gene on the Y chromosome (UTY) protein as an H-Y epitope, H-YD ^b, is a male-specific transplantation antigen H-Y .

HY-P3813

Tyrosinase (206-214), human	Tyrosinase	Inflammation/Immunology Cancer
Tyrosinase (206-214), human (AFLPWHRLF), a 9-amino acid peptide, is a tyrosinase epitope. Tyrosinase (206-214), human can be recognized by HLA-A24 restricted, tumor-infiltrating lymphocytes (TIL) .

HY-P4184A

Isotocin acetate (Ser4,Ile8)-Oxytocin acetate	Peptides	Others
Isotocin (acetate) ((Ser4,Ile8)-Oxytocin (acetate)) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development .

HY-P5745

TYVPANASL

Peptides Cancer

TYVPANASL is a MHC I-binding CD8 T cell epitope of nine amino acids from HER2/neu. TYVPANASL can be used to prepare J-LEAPS vaccine .

HY-P4193

AH1	Peptides	Inflammation/Immunology
AH1 is an immunodominant antigen derived from the gp70 product of an endogenous MuLV. AH1 behaves as the CTL-immunodominant epitope of CT26 colon carcinoma .

HY-P5745A

TYVPANASL TFA

Peptides Cancer

TYVPANASL TFA is a MHC I-binding CD8 T cell epitope of nine amino acids from HER2/neu. TYVPANASL TFA can be used to prepare J-LEAPS vaccine .

HY-P1587

IRBP (1-20), human	Peptides	Inflammation/Immunology
IRBP (1-20), human contains a major epitope for the H-2 ^b haplotype. IRBP (1-20), human induces experimental autoimmune uveoretinitis (EAU) in H-2 ^b mice .

HY-P1587A

IRBP (1-20), human TFA	Peptides	Inflammation/Immunology
IRBP (1-20), human TFA contains a major epitope for the H-2 ^b haplotype. IRBP (1-20), human TFA induces experimental autoimmune uveoretinitis (EAU) in H-2 ^b mice .

HY-P10339

SMCY peptide	Peptides	Inflammation/Immunology
SMCY peptide inhibits the binding of iodinated standard peptide to HLA-B7 with an IC₅₀ of 34 nM. As an epitope of the H-Y antigen, SMCY peptide can be presented by the HLA-B7 molecule and recognized by specific T cells, leading to transplant rejection .

HY-P2527

Tyrosinase-related Protein 2 (TRP-2) (181-188)	Peptides	Inflammation/Immunology
Tyrosinase-related Protein 2 (TRP-2) (181-188) is a tyrosinase-related protein 2 (TRP-2)-derived peptide, corresponding to residues 180-188. Tyrosinase-related Protein 2 (TRP-2) (181-188) is the major reactive epitope within TRP-2 recognized by anti-B16 CTLs. Tyrosinase-related Protein 2 (TRP-2) (181-188) is a peptide conforming to the MHC class I H2-Kb binding motif .

HY-106374

Elpamotide	Peptides	Cancer
Elpamotide is an epitope peptide derived from VEGFR2. Elpamotide induces cytotoxic T lymphocytes (CTLs) to kill VEGFR2-expressing endothelial cells. Elpamotide has potential immunostimulatory and antineoplastic activities. Elpamotide can be used in the research of cancer, such as pancreatic cancer .

HY-P4025

ELDKWA	Peptides	Others
ELDKWA is the highly conserved amino acids on the ecto-domain of gp41. ELDKWA acts as the epitope of a neutralizing monoclonal antibody 2F5 (mAb 2F5) directed against human immunodeficiency virus type 1 .

HY-P3051

CKS-17	Peptides	Inflammation/Immunology
CKS-17 is a synthetic retroviral envelope peptide. CKS-17 has the highly conserved amino acid sequences occurring within the transmembrane envelope protein of many animal and human retroviruses. CKS-17 acts as an immunomodulatory epitope and exhibits suppressive properties for numerous immune functions .

HY-P4032

HCV Peptide (35-44)	HCV	Inflammation/Immunology
HCV Peptide (35-44), a HCV core protein at positions 35 to 44, is a HLA-A2-restricted CTL epitope. HCV Peptide (35-44) inhibits NK cell activity via two distinct mechanisms, directly via KIR2DL2/3, and synergistically via the CD94:NKG2A receptor .

HY-P10382

M133 peptide	Peptides	Inflammation/Immunology
M133 peptide is a coronavirus-specific CD4 T cell epitope. M133 peptide is immunodominant in mice infected with the neurotropic coronavirus (the JHM strain of mouse hepatitis virus). M133 peptide forms a complex with MHC II molecules, which is recognized by specific TCRs, thereby activating CD4 T cells .

HY-P1804

SIYRY

Peptides Others

SIYRY is a K ^b-restricted epitope peptide .

HY-P5294

YLLEMLWRL	Peptides	Cancer
YLLEMLWRL is an HLA-A2-restricted T cell epitope sequence corresponding to codon 125-133. Among them, YLLEMLWRL sequence is the main mutation site of HLA-A2-restricted CTL epitope sequence .

HY-P1762

Influenza NP (147-155)

Influenza Virus Infection

Influenza NP (147-155) is a K ^d restricted epitope from influenza nucleoprotein .
HY-P5667A

VP7 (31-40) peptide acetate

Peptides Others

VP7 (31-40) peptide (acetate) is a polypeptide, VP7 rotavirus protein epitope .
HY-P5667

VP7 (31-40) peptide

Peptides Others

VP7 (31-40) peptide is a polypeptide, VP7 rotavirus protein epitope .

HY-P1862

HSV-gB2 (498-505)	HSV	Infection
HSV-gB2 (498-505) is an immunodominant epitope from herpes simplex virus (HSV) glycoprotein B residues 498-505, acts as H-2Kb-restricted and HSV-1/2-cross-reactive cytotoxic T-lymphocyte (CTL) recognition epitope .

HY-P1762A

Influenza NP (147-155) (TFA)

Influenza Virus Infection

Influenza NP (147-155) TFA is a K ^d restricted epitope from influenza nucleoprotein .
HY-P1780

CEF20

CMV Infection

CEF20 is an HLA-A*0201-restricted epitope from cytomegalovirus pp65 (495-503).
HY-P1870

OVA sequence (323-336)

Peptides Inflammation/Immunology

OVA sequence (323-336) is a cognate helper T-lymphocyte peptide that is employed to enhance CTL epitope immunogenicity.
HY-P1734

Ac-MBP (1-11)

Peptides Neurological Disease

Ac-MBP 1-11, a short peptide sequence, is the major encephalitogenic epitope in myelin basic protein (MBP) .
HY-P5501

Influenza A NP (366-374)

Peptides Others

Influenza A NP (366-374) is a biological active peptide. (H-2Db restricted CTL epitope)

HY-P0329

X-press Tag Peptide	Peptides	Others
X-press Tag Peptide is a tag peptide used for protein purification. X-press Tag is also an N-terminal leader peptide; this N-terminal peptide contains a polyhistidine sequence, the Xpress epitope (part of bacteriophage T7 gene 10 protein) and an enterokinase cleavage site. Anti-Xpress antibodies recognize the Xpress epitope sequence found in this leader peptide.

HY-P5425

Tetanus Toxin (830–844)	Peptides	Others
Tetanus Toxin (830–844) is a biological active peptide. (tetanus toxin-derived peptide TT830–844 CD4+ T-cell epitope. This promiscuous CD4+ T-cell epitope can bind to a wide range of HLA–DRB molecules and is thus expected to activate CD4+ T-cell responses in a large part of the human population)

HY-P4628

TPNQRQNVC

LRH-1 peptide
Peptides Inflammation/Immunology

TPNQRQNVC is a nonapeptide and is the epitope of HLA-B0702. TPNQRQNVC induces a CD8+ T cell immune response .
HY-P1794

G280-9

Peptides Cancer

G280-9 is a 9 amino acid native epitope peptide. G280-9 is a relevant target expressed on melanoma.
HY-P0137

CEF1, Influenza Matrix Protein M1 (58-66)

Influenza Virus Infection

CEF1, Influenza Matrix Protein M1 (58-66) is an epitope derived from the matrix protein of the influenza A virus .
HY-P2531

OVA (329-337)

Peptides Others

OVA (329-337) is a 9-aa core epitope (329–337) located in the C-terminal end of the OVA peptide .

HY-P5451

PLP (178-191)	Peptides	Others
PLP (178-191) is a biological active peptide. (This is amino acids 178 to 191 fragment of the proteolipid protein (PLP), an immunodominant encephalitogenic epitope in SJL mice, one of two major encephalitogenic epitopes. PLP peptide 178 to 191 was compared with another encephalitogenic peptide, 139 to 151. The day of onset of disease induced by PLP 178 to 191 was earlier, but the incidence, severity, and histologic features were indistinguishable.)

HY-P1916

FliC, Serotype a (427-441), S.paratyphi A	Peptides	Infection Inflammation/Immunology
FliC, Serotype a (427-441), S.paratyphi A is amino acids 427 to 441 fragment belongs to the FliC, serotype a of the S. FliC epitope .

Cat. No.	Product Name	Target	Research Area

HY-P99471

Bepranemab UCB 0107	Tau Protein	Neurological Disease
Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research .

HY-P99551

Tosatoxumab KBSA301; AR-301	Antibiotic	Infection
Tosatoxumab (AR-301; KBSA301) is a human immunoglobulin G1 monoclonal antibody that specifically neutralizes alpha-toxin (alpha-hemolysin; Hla) of S. aureus. Tosatoxumab binds to an N-terminal epitope of alpha-toxin, thereby preventing functional toxin pore oligomerisation. Tosatoxumab has the potential for passive immunotherapy in the S. aureus pneumonia as an adjunctive therapy to standard antibiotic agent .

HY-P99856

Docaravimab	RABV	Infection
Docaravimab is an antibody, targeting *ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope* G-III**. Docaravimab can be used in research of Rabies .

HY-P990073

Davutamig REGN-5093	c-Met/HGFR	Cancer
Davutamig (REGN-5093) is a human immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic .

HY-P99628

Futuximab

EGFR Cancer

Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity .
HY-P99968

Clivatuzumab

Mucin Cancer

Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers .
HY-P99615

Felvizumab

SB 209763; RSHZ19
RSV Infection

Felvizumab (SB 209763) is a humanized IgG1κ monoclonal antibody directed to distinct neutralizing epitopes on the F glycoprotein of RSV .

HY-P99380

Zanidatamab ZW 25	EGFR	Cancer
Zanidatamab (ZW25) is a humanised, bispecific monoclonal antibody targeting 2 distinct HER2 epitopes (ECD2 and ECD4). Zanidatamab has anti-tumour activity .

HY-P99586

Suptavumab REGN2222	RSV	Infection
Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection .

HY-P99859

Donanemab LY3002813	Amyloid-β	Neurological Disease
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research .

HY-P99538

Ublituximab LFB-R603; TG-1101; TGTX-1101	CD20	Cancer
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects .

HY-P99634

Gatipotuzumab PankoMab	Mucin	Cancer
Gatipotuzumab (PankoMab) is a humanized monoclonal antibody which recognizes the tumor-specific epitope of mucin-1 (TA-MUC1). Gatipotuzumab reveals a potent tumor-specific antibody-dependent cell cytotoxicity (ADCC) .

HY-P99435

Amubarvimab BRII-196	SARS-CoV	Infection
Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a K_D of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants .

HY-P99727

Mazorelvimab SYN023	RABV	Infection
Mazorelvimab (SYN023) is a combination of CTB011 and CTB012 humanized monoclonal antibodies cocktail against rabies virus (RABV). Mezagitamab binds to non-overlapping epitopes on RABV glycoprotein (G). Mezagitamab has potential application in the prevention of rabies .

HY-P99559

Tilogotamab GEN-1029; HexaBody-DR5/DR5; Hx-DR5-01/05	Inhibitory Antibodies	Cancer
Tilogotamab (GEN-1029) is an agonistic hexamer formation-enhanced mixture of two antibodies that target two separate epitopes on death receptor type 5 (DR5). Tilogotamab specifically binds to and activates DR5. Tilogotamab can be used for the research of multiple myeloma (MM) .

HY-P99513

Zamerovimab CTB011; SYN023	RABV	Infection
Zamerovimab (CTB011; SYN023) is a mixture of human monoclonal antibodies consisting of CTB011 and CTB012. Zamerovimab binds to non-overlapping epitopes on rabies virus (RABV) glycoprotein, where CTB011 binds to antigenic site III. Zamerovimab can be used in rabies studies .

HY-P99306

Modotuximab DS 1024; Sym 004	Inhibitory Antibodies	Cancer
Modotuximab (Anti-Human EGFR Recombinant Antibody) is an IgG1κ-type chimeric antibody targeting human EGFR protein. Modotuximab contains a portion of Futuximab that binds to two independent, non-overlapping epitopes on EGFR. Modotuximab promotes cross-linking of EGFR on the cell surface and promotes EGFR cellular internalization and degradation. Modotuximab has antitumor activity in vivo .

HY-P990094

Trabikibart CSL311	Inhibitory Antibodies	Inflammation/Immunology
Trabikibart (CSL311), a βc-specific, fully human monoclonal antibody, binds to a unique epitope that is specific to the cytokine-binding site of the human βc receptor. Trabikibart has picomolar binding affinity for the human βc receptor. Trabikibart is a potent inhibitor of the combined effects of IL-3, GM-CSF and IL-5 on the survival of eosinophils. Trabikibart has the potential for chronic inflammatory diseases research .

HY-145642

Masavibart ZRC3308-A7	SARS-CoV	Infection
Masavibart (ZRC3308-A7) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Masavibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Masavibart can be used in combination with ZRC3308-B10 (HY-145643) at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease .

HY-145643

Nepuvibart ZRC3308-B10	SARS-CoV	Infection
Nepuvibart (ZRC3308-B10) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Nepuvibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Nepuvibart can be used in combination with ZRC3308-A7 (HY-145642) at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease .

HY-P990090

Rademikibart CBP-201	Interleukin Related	Inflammation/Immunology
Rademikibart (CBP-201) is a human monoclonal antibody targeting IL-4Rα with a KD of 20.7 pM when binding to human IL-4Rα epitopes. Rademikibart does not bind to IL-4Rα from other species. Rademikibart inhibits IL-4 and IL-13-mediated STAT6 signaling, TF-1 cell proliferation and TARC production in PBMCs. Rademikibart has the potential for moderate-to-severe Th2 inflammatory diseases research .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N11140

Glu-Lys	Structural Classification Ketones, Aldehydes, Acids Source classification Endogenous metabolite	Others
Glu-Lys is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development .

HY-N10510

Blood group A antigen tetraose type 5 A-Tetrasaccharide	Structural Classification Natural Products Polysaccharides Classification of Application Fields Other Diseases Endogenous metabolite Disease Research Fields Saccharides	Others
Blood group A antigen tetraose type 5 (A-Tetrasaccharide) is a tetrasaccharide and a blood group specific oligosaccharide, inhibits the binding of anti-A antibody to blood group A substance. Blood group A antigen tetraose type 5 can be isolated from polar bear milk samples .

Cat. No.	Product Name	Chemical Structure

HY-P4229

([D8]Val7,10)-C-Peptide (human)
([D8]Val7,10)-C-Peptide (human) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development .

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P80948B

	HA tag Antibody (YA3393) HA Epitope tag antibody; HA1; HA2; hemagglutinin antibody	WB, ICC/IF, IP	Species independent
	Anti-HA tag Antibody is a non-conjugated and Rabbit origined monoclonal antibody. It can be used for WB, IF-Cell, IP assays in the background of .


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

Natural
Products

Isotope-Labeled Compounds

Antibodies

Epitope

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

NaturalProducts

Isotope-Labeled Compounds

Antibodies

Natural
Products